|
US3475466A
(en)
*
|
1965-08-30 |
1969-10-28 |
Schering Corp |
Novel 17,21-diesters of 16alpha-methyl-9alpha,11beta-dichloro-1,4- pregnadienes
|
|
US3422193A
(en)
*
|
1966-08-11 |
1969-01-14 |
Schering Corp |
17-mono esters of corticoids
|
|
IT1061787B
(it)
*
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
|
GB1281689A
(en)
*
|
1968-10-14 |
1972-07-12 |
Glaxo Lab Ltd |
Steroid 21-phosphates
|
|
US3694471A
(en)
*
|
1970-06-08 |
1972-09-26 |
Warner Lambert Pharmaceutical |
17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
|
|
DK135267A
(xx)
*
|
1971-02-25 |
|
|
|
|
US3789121A
(en)
*
|
1971-11-26 |
1974-01-29 |
Warner Lambert Co |
17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
|
|
GB1429184A
(en)
*
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
|
US4044126A
(en)
*
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
|
DE2512915A1
(de)
*
|
1974-03-27 |
1975-10-09 |
Plurichemie Anstalt |
16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung
|
|
US4018918A
(en)
*
|
1975-05-20 |
1977-04-19 |
The Upjohn Company |
Topical clindamycin preparations
|
|
DE2645104C2
(de)
*
|
1976-10-04 |
1986-04-24 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
|
|
US4070462A
(en)
*
|
1976-10-26 |
1978-01-24 |
Schering Corporation |
Steroid ointment
|
|
JPS6040439B2
(ja)
*
|
1978-03-29 |
1985-09-11 |
大正製薬株式会社 |
ヒドロコルチゾン誘導体
|
|
DE3068965D1
(en)
*
|
1979-11-16 |
1984-09-20 |
Sterosynt Ltd |
6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
|
|
US4350690A
(en)
*
|
1980-10-27 |
1982-09-21 |
Cressington Investments Ltd. |
Steroid composition
|
|
US4346086A
(en)
*
|
1981-06-09 |
1982-08-24 |
Beiersdorf Aktiengesellschaft |
Corticosteroid-containing cream
|
|
IL66432A0
(en)
*
|
1981-08-04 |
1982-12-31 |
Plurichemie Anstalt |
Process for the preparation of steroidal esters
|
|
DE3133081A1
(de)
*
|
1981-08-18 |
1983-03-10 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
|
|
FR2515041A1
(fr)
*
|
1981-10-26 |
1983-04-29 |
Besins Jean |
Medicament a base de progesterone pour le traitement des affections mammaires
|
|
EP0095894A3
(en)
*
|
1982-05-31 |
1985-01-02 |
Ohta Seiyaku Kabushiki Kaisha. |
6 alpha-methylprednisolone derivatives
|
|
DE3227312A1
(de)
*
|
1982-07-19 |
1984-01-19 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
|
|
DE3243482A1
(de)
*
|
1982-11-22 |
1984-05-24 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
|
|
US4489070A
(en)
*
|
1983-05-13 |
1984-12-18 |
Schering Corporation |
Betamethasone dipropionate cream
|
|
US4482539A
(en)
*
|
1983-05-13 |
1984-11-13 |
Schering Corporation |
Betamethasone dipropionate cream
|
|
DE3400188A1
(de)
*
|
1984-01-02 |
1985-07-11 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
Neue 6(alpha),16(alpha)-dimethylkortikoide
|
|
PT78973A
(en)
*
|
1984-07-25 |
1984-08-01 |
Joao Emerico Villax |
New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
|
|
MY105368A
(en)
*
|
1990-03-02 |
1994-09-30 |
Glaxo Group Ltd |
Inhalation device.
|
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
|
SK280968B6
(sk)
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Balenie medikamentu na použite v inhalačnom prístroji
|
|
US6759398B2
(en)
*
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
AR032471A1
(es)
*
|
2000-08-05 |
2003-11-12 |
Glaxo Group Ltd |
Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
|
|
US6858596B2
(en)
*
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
US6777399B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
GB0019172D0
(en)
*
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
|
CA2445839A1
(en)
*
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
US20040248867A1
(en)
*
|
2001-06-12 |
2004-12-09 |
Keith Biggadike |
Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
|
|
AU2002356759A1
(en)
*
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
|
US20050175545A1
(en)
*
|
2002-02-04 |
2005-08-11 |
Keith Biggadike |
Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
|
|
GB0202635D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Wellcome Mfg Pte Ltd |
Formulation containing novel anti-inflammatory androstane derivative
|
|
GB2389530B
(en)
*
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
|
EP1663999A2
(en)
*
|
2003-08-29 |
2006-06-07 |
Ranbaxy Laboratories, Ltd. |
Inhibitors of phosphodiesterase type-iv
|
|
WO2005051931A2
(en)
*
|
2003-11-26 |
2005-06-09 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
|
US20080009535A1
(en)
*
|
2004-08-30 |
2008-01-10 |
Sarala Balachandran |
Inhibitors of phosphodiesterase type-IV
|
|
GB0507165D0
(en)
*
|
2005-04-08 |
2005-05-18 |
Glaxo Group Ltd |
Novel crystalline pharmaceutical product
|
|
US7915286B2
(en)
|
2005-09-16 |
2011-03-29 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
|
AU2006305620A1
(en)
*
|
2005-10-19 |
2007-04-26 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
|
CA2626612A1
(en)
|
2005-10-19 |
2007-04-26 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of muscarinic receptor antagonists
|
|
GB0615108D0
(en)
*
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel formulations
|
|
EP2066661A2
(en)
*
|
2006-09-22 |
2009-06-10 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
|
CN101616901A
(zh)
*
|
2006-09-22 |
2009-12-30 |
兰贝克赛实验室有限公司 |
Iv型磷酸二酯酶的抑制剂
|
|
US20080207659A1
(en)
*
|
2007-02-15 |
2008-08-28 |
Asit Kumar Chakraborti |
Inhibitors of phosphodiesterase type 4
|
|
US20110130403A1
(en)
*
|
2007-03-14 |
2011-06-02 |
Ranbaxy Laboratories Limited |
Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
|
|
CN103497185A
(zh)
|
2007-03-14 |
2014-01-08 |
兰贝克赛实验室有限公司 |
用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
|
|
US8796248B2
(en)
*
|
2007-10-05 |
2014-08-05 |
Nektar Therapeutics |
Oligomer-corticosteroid conjugates
|
|
EP2111861A1
(en)
|
2008-04-21 |
2009-10-28 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
|
CN112358522B
(zh)
*
|
2020-05-18 |
2021-11-16 |
河南利华制药有限公司 |
一种倍他米松二丙酸酯的精制方法及倍他米松二丙酸酯
|
|
CN111944002A
(zh)
*
|
2020-07-29 |
2020-11-17 |
河南利华制药有限公司 |
一种倍氯米松二丙酸酯中间体及制备方法
|
|
CN116023425B
(zh)
*
|
2023-03-28 |
2023-06-20 |
南京师范大学 |
曲安西龙衍生物及其医药用途
|